Production (Stage)
Generation Bio Co.
GBIO
$0.383
-$0.008-2.05%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.72M | 4.19M | 7.55M | 4.09M | 4.06M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.72M | 4.19M | 7.55M | 4.09M | 4.06M |
| Cost of Revenue | 11.75M | 12.20M | 11.86M | 12.91M | 10.80M |
| Gross Profit | -3.02M | -8.01M | -4.30M | -8.82M | -6.75M |
| SG&A Expenses | 12.45M | 12.33M | 12.41M | 12.89M | 13.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.19M | 24.53M | 24.27M | 25.80M | 24.76M |
| Operating Income | -15.47M | -20.34M | -16.72M | -21.71M | -20.70M |
| Income Before Tax | -14.80M | -21.38M | -15.31M | -20.43M | -74.54M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.80M | -21.38M | -15.31M | -20.43M | -74.54M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.80M | -21.38M | -15.31M | -20.43M | -74.54M |
| EBIT | -15.47M | -20.34M | -16.72M | -21.71M | -20.70M |
| EBITDA | -14.33M | -19.17M | -15.54M | -20.45M | -19.39M |
| EPS Basic | -0.22 | -0.32 | -0.23 | -0.31 | -1.12 |
| Normalized Basic EPS | -0.13 | -0.17 | -0.13 | -0.18 | -0.17 |
| EPS Diluted | -0.22 | -0.32 | -0.23 | -0.31 | -1.12 |
| Normalized Diluted EPS | -0.13 | -0.17 | -0.13 | -0.18 | -0.17 |
| Average Basic Shares Outstanding | 67.00M | 66.79M | 66.74M | 66.53M | 66.43M |
| Average Diluted Shares Outstanding | 67.00M | 66.79M | 66.74M | 66.53M | 66.43M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |